These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23595948)

  • 41. Intravenous immunoglobulin and multiple sclerosis.
    Achiron A; Miron S
    Clin Rev Allergy Immunol; 2005 Dec; 29(3):247-54. PubMed ID: 16391400
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interferon beta for treatment of multiple sclerosis.
    Wilson BA
    Medsurg Nurs; 1995 Apr; 4(2):151-3. PubMed ID: 7711824
    [No Abstract]   [Full Text] [Related]  

  • 43. Should all patients with an initial diagnosis of multiple sclerosis be treated with beta interferon?
    Hodgkinson SJ
    J Clin Neurosci; 2001 Jul; 8(4):378-9. PubMed ID: 11437587
    [No Abstract]   [Full Text] [Related]  

  • 44. Vitiligo and multiple sclerosis in a patient treated with interferon beta-1a: a case report.
    Kocer B; Nazliel B; Oztas M; Batur HZ
    Eur J Neurol; 2009 Apr; 16(4):e78-9. PubMed ID: 19222549
    [No Abstract]   [Full Text] [Related]  

  • 45. Should all patients with an initial diagnosis of multiple sclerosis be treated with beta interferon? The case against.
    Macdonell R
    J Clin Neurosci; 2001 Jul; 8(4):379-81. PubMed ID: 11437588
    [No Abstract]   [Full Text] [Related]  

  • 46. Interferons in multiple sclerosis.
    Kappos L
    Neurol Clin; 2005 Feb; 23(1):189-214, vii-viii. PubMed ID: 15661094
    [No Abstract]   [Full Text] [Related]  

  • 47. [High doses of interferon in the treatment of multiple sclerosis].
    Muñoz D
    Rev Neurol; 2001 May 1-15; 32(9):899. PubMed ID: 11424041
    [No Abstract]   [Full Text] [Related]  

  • 48. Why interferon beta 1b was licensed is a mystery.
    Harvey P
    BMJ; 1996 Aug; 313(7052):297-8. PubMed ID: 8704553
    [No Abstract]   [Full Text] [Related]  

  • 49. Interferon-beta treatment in patients with childhood-onset multiple sclerosis.
    Mikaeloff Y; Moreau T; Debouverie M; Pelletier J; Lebrun C; Gout O; Pedespan JM; Van Hulle C; Vermersch P; Ponsot G
    J Pediatr; 2001 Sep; 139(3):443-6. PubMed ID: 11562627
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Problems and prospects of beta-interferon and copaxone++ application in the treatment of multiple sclerosis].
    Gusev EI; Boĭko AN; Pozer Ch
    Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(4):33-6. PubMed ID: 10319395
    [No Abstract]   [Full Text] [Related]  

  • 51. [New trends, clinical questions and long-term experiences. Therapy of multiple sclerosis with interferon beta-1b].
    Nervenarzt; 1998 Nov; 69(11 Suppl Therapie D):1-8. PubMed ID: 9845885
    [No Abstract]   [Full Text] [Related]  

  • 52. Betaseron: a breakthrough treatment for multiple sclerosis.
    Morrison W; Nelson J
    Can Nurse; 1996 Oct; 92(9):38-41. PubMed ID: 9118060
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treating multiple sclerosis with vitamin D.
    Chataway J
    J Neurol Neurosurg Psychiatry; 2012 May; 83(5):473. PubMed ID: 22410370
    [No Abstract]   [Full Text] [Related]  

  • 54. [The use of beta-interferon-1b in children and adolescents with multiple sclerosis].
    Bykova OV; Kuzenkova LM; Maslova OI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(9):29-33. PubMed ID: 17069059
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 10 years of interferon beta-1b (Beta feron therapy.
    Kappos L; Hartung HP
    J Neurol; 2005 Sep; 252 Suppl 3():iii1-iii2. PubMed ID: 16170493
    [No Abstract]   [Full Text] [Related]  

  • 56. [Betaferon and therapy of multiple sclerosis--present and future].
    Hohlfeld R
    Med Klin (Munich); 2001 Sep; 96 Suppl 1():1. PubMed ID: 11603109
    [No Abstract]   [Full Text] [Related]  

  • 57. Interferon β-1a for multiple sclerosis: old drug, new clothes.
    Hartung HP
    Lancet Neurol; 2014 Jul; 13(7):638-9. PubMed ID: 24878062
    [No Abstract]   [Full Text] [Related]  

  • 58. The use of interferon beta in relapsing-remitting multiple sclerosis.
    Etheridge LJ; Beverley DW; Ferrie C; McManus E
    Arch Dis Child; 2004 Aug; 89(8):789-91. PubMed ID: 15269086
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [New therapeutic methods in the treatment of multiple sclerosis].
    Nervenarzt; 1996 Nov; 67(11 Suppl Neue Ther):1-12. PubMed ID: 9402424
    [No Abstract]   [Full Text] [Related]  

  • 60. Injecting rationale into interferon-beta therapy.
    Reder AT; Antel JP
    Neurology; 2000 Jun; 54(11):2034-5. PubMed ID: 10851357
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.